London Daily

Focus on the big picture.
Monday, Feb 09, 2026

Covid: UK vaccine booster scheme likely to start in September - Sajid Javid

Covid: UK vaccine booster scheme likely to start in September - Sajid Javid

A UK Covid vaccine booster scheme will take place and is likely to start next month, the health secretary has said.

Sajid Javid said he was uncertain of the exact start date as the government was waiting for the Joint Committee on Vaccination and Immunisation's "final advice" before proceeding.

Mr Javid added the "most vulnerable" would be offered the third jab first.

However, it remains unclear whether the booster scheme will be for all adults, or just some, more vulnerable groups.

Interim advice from the JCVI, released last month, suggested more than 30 million of the most vulnerable people - including all over-50s - should receive a third dose.

Asked about the scheme on Thursday, Mr Javid said: "We are going to have a booster scheme. It will start some time in September.

"I couldn't tell you exactly when because before we start it... we need to get the final advice from our group of experts, our independent scientific and medical advisers, the JCVI, and so we're waiting for their final opinion."

Earlier in the day, Prof Adam Finn told the BBC that the JCVI, of which he is a member, would be "imminently deciding" that some people "will need a third dose, particularly people who we know are very unlikely to be well protected by those first two doses".

"But I think we do need more evidence before we can make a firm decision on a much broader booster programme," he added.


The health secretary says "a" booster campaign will take place, but the more important question is "who" will be boosted. We still don't know.

There are scientific and ethical arguments about a booster campaign.

For some there is a clear benefit - particularly those with weakened immune systems in whom it takes three doses to do the job of two.

But for the rest of the population, the evidence so far shows two doses are providing lasting protection from becoming seriously ill and needing hospital treatment.

Whether a mass vaccination campaign is necessary or should be far more targeted is the subject of intense debate.

This comes at a time that rich countries are being accused of giving vaccines to people at little risk from Covid and that would save far more lives if they were shared with the world.

About 70% of the entire UK population has had at least one jab. In the poorest countries that figure is about 1%.


The announcement comes after it was revealed more than 125,000 16 and 17-year-olds in England have had the vaccine in the two weeks since the NHS was given approval to offer that age group a jab.

In total, 47,460,526 first doses have now been given across the UK, while 41,157,069 people have had two doses.

But the decision to offer people in the UK a third jab is not without controversy.

Immunologist Prof Peter Openshaw, a member of the New and Emerging Respiratory Virus Threats Advisory Group (Nervtag), which advises the government, said the "question about boosters is a contentious one".

He said studies into the effectiveness of booster schemes were still ongoing and "everyone is very keen that if we do have surplus vaccines, that they're not necessarily used in this country, but might be sent overseas".

And, earlier this month, the head of the Oxford Vaccine Group said doses needed to "go where they can have the greatest impact" - to protect unvaccinated people abroad.

Prof Sir Andrew Pollard, who led the team that created the Oxford-AstraZeneca vaccine, said decisions on whether to give boosters "should be scientifically driven".

Asked whether the JCVI had concerns about plans for the booster scheme, Mr Javid said: "It's only with their expert advice that government would want to continue with their plans.

"I don't want to prejudge what they're going to say but, based on their interim advice, I think we can be confident that we will start a booster scheme next month."



Immunologist Prof Peter Openshaw: "The question of boosters is a contentious one"


Newsletter

Related Articles

0:00
0:00
Close
China and UK Signal Tentative Reset with Commitment to Steadier, Professionally Managed Relations
UK Confirms Imminent Increase in ETA Fee to £20 as Entry Rules Tighten
UK Signals Possible Seizure of Russia-Linked ‘Shadow Fleet’ Tanker in Escalation of Sanctions Enforcement
Epstein Scandal Piles Unprecedented Pressure on UK Prime Minister Keir Starmer’s Leadership
UK’s ‘Most Romantic Village’ Celebrates Valentine’s Day and Explores the Festival’s Rich History
The Implications of Expanding Voting Rights to Non-EU Foreign Residents in France
Ghislaine Maxwell to Testify Before US Congress on February 9
Al.com Acquired by Crypto.com Founder for $70 Million
Apple iPhone Lockdown Mode blocks FBI data access in journalist device seizure
Belgium: Man Charged with Rape After Faking Payment to Sex Worker
KPMG Urges Auditor to Relay AI Cost Savings
US and Iran to Begin Nuclear Talks in Oman
Winklevoss-Led Gemini to Slash a Quarter of Jobs and Exit European and Australian Markets
Canada Opens First Consulate in Greenland Amid Rising Geopolitical Tensions
China unveils plans for a 'Death Star' capable of launching missile strikes from space
NASA allows astronauts to take smartphones on upcoming missions to capture special moments.
Trump administration to launch TrumpRx.gov for direct drug purchases
Investigation Launched at Winter Olympics Over Ski Jumpers Injecting Hyaluronic Acid
U.S. State Department Issues Urgent Travel Warning for Citizens to Leave Iran Immediately
Wall Street Erases All Gains of 2026; Bitcoin Plummets 14% to $63,000
Epstein Case Documents Reignite Global Scrutiny of Political and Business Elites
Eighty-one-year-old man in the United States fatally shoots Uber driver after scam threat
UK Royal Family Faces Intensifying Strain as Epstein-Linked Revelations Rock the Institution
Political Censorship: French Prosecutors Raid Musk’s X Offices in Paris
AI Invented “Hot Springs” — Tourists Arrived and Were Shocked
Tech Mega-Donors Power Trump-Aligned Fundraising Surge to $429 Million Ahead of 2026 Midterms
UK Pharma Watchdog Rules Sanofi Breached Industry Code With RSV Vaccine Claims Against Pfizer
Melania Documentary Opens Modestly in UK with Mixed Global Box Office Performance
Starmer Arrives in Shanghai to Promote British Trade and Investment
Harry Styles, Anthony Joshua and Premier League Stars Among UK’s Top Taxpayers
New Epstein Files Include Images of Former Prince Andrew Kneeling Over Unidentified Woman
Starmer Urges Former Prince Andrew to Testify Before US Congress About Epstein Ties
Starmer Extends Invitation to Japan’s Prime Minister After Strategic Tokyo Talks
Skupski and Harrison Clinch Australian Open Men’s Doubles Title in Melbourne
DOJ Unveils Millions of Epstein Files, Fueling Global Scrutiny of Elite Networks
France Begins Phasing Out Zoom and Microsoft Teams to Advance Digital Sovereignty
China Lifts Sanctions on British MPs and Peers After Starmer Xi Talks in Beijing
Trump Nominates Kevin Warsh as Fed Chair to Reorient U.S. Monetary Policy Toward Pro-Growth Interest Rates
AstraZeneca Announces £11bn China Investment After Scaling Back UK Expansion Plans
Starmer and Xi Forge Warming UK-China Ties in Beijing Amid Strategic Reset
Tech Market Shifts and AI Investment Surge Drive Global Innovation and Layoffs
Markets Jolt as AI Spending, US Policy Shifts, and Global Security Moves Drive New Volatility
U.S. Signals Potential Decertification of Canadian Aircraft as Bilateral Tensions Escalate
Former South Korean First Lady Kim Keon Hee Sentenced to 20 Months for Bribery
Tesla Ends Model S and X Production and Sends $2 Billion to xAI as 2025 Revenue Declines
China Executes 11 Members of the Ming Clan in Cross-Border Scam Case Linked to Myanmar’s Lawkai
Trump Administration Officials Held Talks With Group Advocating Alberta’s Independence
Starmer Signals UK Push for a More ‘Sophisticated’ Relationship With China in Talks With Xi
Shopping Chatbots Move From Advice to Checkout as Walmart Pushes Faster Than Amazon
Starmer Seeks Economic Gains From China Visit While Navigating US Diplomatic Sensitivities
×